Latest Earnings Results: Q2 '26
Estimated EPS
$1.23
Reported EPS
$1.31
Surprise
+6.82%
Estimated Rev
$1.13B
Reported Rev
$1.16B
Surprise
+2.51%
• Reported GAAP EPS of $1.37 down -8.05% YoY • Reported revenue of $1.16B up 9.44% YoY • Illumina now expects fiscal year 2026 total revenue of $4.60-$4.64 billion, ROW organic revenue growth greater than 5%, non-GAAP operating margin of 23.4%-23.6%, and non-GAAP diluted EPS of $5.30-$5.40.
Bullish Takeaway
Illumina delivered revenue growth and improved operating margins during the quarter, leading the company to raise its full-year 2026 financial guidance due to strong demand for its NovaSeq X technology.
Bearish Takeaway
Illumina experienced a decline in GAAP diluted EPS and free cash flow during the quarter, while also navigating structural risks related to its inclusion on China's Unreliable Entities List.
Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.
Historical Earnings
Quarterly
Annual
EPS
Revenue
| Fiscal Period | Estimated | Reported | Surprise | Result |
|---|---|---|---|---|
Q3 '26 | $1.35 | -- | -- | N/A |
Q2 '26 | $1.23 | $1.31 | 6.82% | BEAT |
Q1 '26 | $1.05 | $1.15 | 9.06% | BEAT |
Q4 '25 | $1.24 | $1.35 | 8.70% | BEAT |
Q3 '25 | $1.17 | $1.34 | 14.68% | BEAT |